The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature
With the advent of immunotherapy and with the expanding spectrum of malignancies treated with immunomodulatory agents, a new kind of adverse events has come under the spotlight. Clinicians have to be aware of immune-related adverse events and their clinical manifestations. Immunotherapy has been str...
Main Authors: | George Zarkavelis, Davide Mauri, Fotini Karassa, Kampletsas Eleftherios, George Pentheroudakis, Alexandra Pappadaki, Leonidas Mavroeidis, Panagiotis Ntellas, Stefania Gkoura, Ioanna Gazouli |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2020-03-01
|
Series: | Contemporary Oncology |
Subjects: | |
Online Access: | https://www.termedia.pl/The-cancer-immunotherapy-environment-may-confound-the-utility-of-anti-TIF-1-in-differentiating-between-paraneoplastic-and-treatment-related-dermatomyositis-Report-of-a-case-and-review-of-the-literatur,3,40484,1,1.html |
Similar Items
-
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report
by: Chikako Shibata, et al.
Published: (2019-06-01) -
Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
by: Yorihisa Kotobuki, et al.
Published: (2021-01-01) -
ASSESSMENT AND MANAGEMENT OF A PATIENT WITH PARANEOPLASTIC DERMATOMYOSITIS
by: Ioan-Cristian Lupescu, et al.
Published: (2017-12-01) -
Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis
by: Dario Didona, et al.
Published: (2020-03-01) -
Dermatomyositis as a paraneoplastic syndrome of malignant melanoma or incidental coexistence?
by: Magdalena Krajewska, et al.
Published: (2016-09-01)